Corporate ManufacturerCached Profile
OTSUKA AMERICA PHARMACEUTICAL
Manufacturer Corporate ID: 100000010723
Subsidiaries Logged: 1 entities
LIFETIME CORPORATE SPEND
$5,050,424
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Top Funded Physicians
Physicians receiving the highest promotional payments from this corporation.
1. Dr. BRIAN BONFARDINMedical Doctor
$394,9452. Dr. AMITA PATELMedical Doctor
$352,4833. Dr. AHMED NIZARMedical Doctor
$254,4734. Dr. ADAM ASHTONMedical Doctor
$248,8255. Dr. CARMEN PINTOMedical Doctor
$218,533Top Promoted Products
Drugs or medical devices receiving the highest marketing backing.
1. REXULTI$3,342,185 (66.2%)
2. ABILIFY MAINTENA$997,828 (19.8%)
3. JYNARQUE$224,814 (4.5%)
4. NUEDEXTA$190,248 (3.8%)
5. ABILIFY ASIMTUFII$107,431 (2.1%)
Active Subsidiary Entities
Corporate subsidiaries and brands associated with this manufacturer ID in Open Payments.
OTSUKA AMERICA PHARMACEUTICAL, INC.
Corporate General Payouts Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2025
2025
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for OTSUKA AMERICA PHARMACEUTICAL...